Ces radiol. 2009, 63(3):210-216
MR enterography using experimental SPIO oral contrast agent - first experiencesOriginal article
- 1 Radiologické oddelenie, FNsP F. D. Roosevelta, Banská Bystrica, Slovenská republika
- 2 Výzkumné centrum nanomateriálů, UP Olomouc
- 3 Katedra fyzikálnej chémie, UP Olomouc
- 4 MEDIHOPE s.r.o., Prostějov
- 5 Rádiologická klinika LF a FNsP, UP Olomouc
Aim: Magnetic resonance is a method of choice in small bowel imaging according to high resolution of soft tissue, multiplanar acquisition, possibility of functional studies, absence of radiation, especially in children and younger population. From technical point of view small bowel preparation is necessary - sufficient distension, avoiding of motion artifacts, acceptable examination time. Small bowel distension can be reached in 2 ways, peroral filling or fillling through nasojejunal tube. Oral contrast agents are characterized as positive, negative or biphasic.
Method: Study is divided into 3 groups. There are 17 healthy volunteers in the first group. After 6-8 hours of fasting, they drank fractionally 1000 ml peroral solution within 50 minutes. Then followed MREg (magnetic resonance enterography) without intravenous contrast agent and spasmolytic agent. Second group was realized in 24 patients with MRCP (magnetic resonance pancreatico-cholangiography) with various diagnoses, as small bowel preparation we gave them 500 ml of peroral solution fractionally within 30 minutes. Last group consists of patients with Crohn's disease, inflammatory bowel disease, etc, study is not finished yet. All examinations were realized on 1,5T system (Signa Horizon Lx, GE, Milwaukee, Wisconsin, USA), examination protocol in MREg: breathhold axial/coronal plane 2D T2 SSFSE (single-shot fast spine-scho), all patients and volunteers fulfilled questionnaire about the solution characterization, 4 radiologists independently evaluated the examinations in first two groups. Third group was not statistically analyzed because of it is not finished yet. Analysis was made by statistic methods of χ2-test of good agreement and contingent tables with level of significance 5%.
Results: Evaluation of the questionnaires about solution characterization in first and second group resulted in existence of dependence on solution taste and appearance, fruity taste is connected with sufficient appearance and good solution taste, metalic and synthetic taste is connected with bad appearance and not good solution taste. According to statistic analysis, there is dependence between problems during drinking (diarrhoe, nausea, flatulence and gargoism) and problems remaining 2 hours after drinking solution. There was seen dependance between metalic, synthetic solution taste, associated nausea respectively. Adverse effects during drinking and after 2 hours drinking (diarrhoe, nausea, flatulence and gargoism) were present in both groups in dependance of solution taste and volume. Evaluation of MREg, MRCP, T2 weighted images is dependend on quality of luminal filling according to statistical analysis and 4 radiologists evaluation of first and second group. In 95% all 4 radiologists were agreed in answers for questions. Based on evalution of the questionnaires, 800 mg maghemit/4 g bentonit in 1000 ml of solution is sufficient concentration.
Conclusion: Oral contrast agent with SPIO nanoparticles of maghemit (800 mg) in bentonit matrix in 1000 ml solution, is appropriate for small bowel examination with MREg. Further study will be necessary for evaluation of inflammatory bowel diseases and MREg with SPIO oral contrast agent.
Keywords: magnetic resonance enterography (MREg), oral contrast agent, small bowel, SPIO (Super Paramagnetic Iron Oxides) particles
Grants and funding:
Článok vznikol v rámci grantového projektu CEP 1MO5512 Centrum práškových nanomateriálu na výzkumu SPIO perorální kontrastní látky při vyšetření tenkého střeva.
Accepted: August 15, 2009; Published: September 1, 2009 Show citation
References
- Maccioni F, Bruni A,Viscido A, Colaiacomo MCh, Cocco A, Montesani Ch, et al. MR imaging in patiens with Crohn disease: value of T2 - versus T1 - weighted gadolinium - enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2005; 238: 517-530.
Go to original source...
Go to PubMed...
- Lauenstein TC, Schneemann H, Vogt FM, Herborn ChU, Ruhm SG, Debatin JF. Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 2003; 228: 279-283.
Go to original source...
Go to PubMed...
- Laghi A, Carbone I, Catalano C, Iannaccone R, Paolantonio P, Baeli I, Trenna S, Passariello R. Polyethylenglycol solution as an oral contrast agent for MR imaging of the small bowel. AJR 2001; 177: 1333-1334.
Go to original source...
Go to PubMed...
- Laghi A, Paolantonio P, Iafrate F, Borrelli O, Dito L, Tomei E, et al. MR of the small bowel with a biphasic oral contrast agent(polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease. Radiol Med 2003; 106: 18-27.
- Kluchova K, Zboril R, Tucek J, Pecova M, Zajoncova L, Safarik I, et al. Superparamagnetic maghemite nanoparticles from solid - state synthesis - their functionalization towards peroral MRI contrast agent and magnetic carrier for trypsin immobilization. Biomaterials 2009; 30: 2855-2863.
Go to original source...
Go to PubMed...
- Kinner S, Kuehle ChA, Herbig S, Haag S, Ladd SC, Barkhausen J, et al. MRI of the small bowel: can sufficient bowel distension be achieved with small volumes of oral contrast? Eur Radiol 2008; 18: 2542-2548.
Go to original source...
Go to PubMed...
- Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N. MR enteroclysis imaging of Crohn's disease. Radiographics 2001; 21: S61-S72.
Go to original source...
Go to PubMed...
- Laghi A. MRI with or without anteroclysis. Postgraduate Educational programme ECR 2009. Book af Abstracts 2009; 19 (Suppl).
- Válek V, Hustý J. Crohn's disease: Clinical-surgical questions and imaging answers. Eur J Radiol 2009; 69: 375-380.
Go to original source...
Go to PubMed...
- Cammarota T, Sarno A, Robotti D, Bonenti G, Debani P, Versace K, et al. US evaluation of patients affected by IBD: How to do it, methods and findings. Eur J Radiol 2009; 69: 429-437.
Go to original source...
Go to PubMed...
- Klibanov AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem 2005; 16: 9-17. Available from: http://en.wikipedia.org/wiki/Contrast-enhanced_ultrasound
Go to original source...
Go to PubMed...
- Válek V, Kysela P, Vavríková M. Crohn's disease at the small bowel imaging by the ultrasound-enteroclysis. Eur J Radiol 2007; 62(2): 153-159.
Go to original source...
Go to PubMed...
- Ferda J, Koželuhová J, Kastner J, Vondráková R, Kreuzberg B, Baxa J, et. Využití MR enterografie v zobrazení Crohnovy nemoci. Čes Radiol 2006; 60: 203-208.
- Mírka H, Ferda J, Ohlídalová K, Koželuhová J. Hodnocení dynamiky perfuze střevní stěny při stanovení aktivity Crohnovy choroby: Porovnání ultrasonografie a magnetické rezonance s blood-pool kontrastní látkou. Čes Radiol 2009; 63: 42-47.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.